Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th iPSC Drug Development and Manufacturing Summit

Evvnt Promotion / evvnt
-
01.10.2024 - 03.10.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temi della conferenza
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832

Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2453698-2?pid=4832
Mr. Elliot Karmel
 
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Helix - Forschung & Beratung WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltSwiss Tropical and Public Health InstituteÄrztekammer für WienAMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthAlumni Club Medizinische Universität Wien